NasdaqGS:ANABBiotechs
Is AnaptysBio (ANAB) Undervalued After Its Recent Share Price Swings?
AnaptysBio (ANAB) has drawn investor attention after recent share price moves, with the stock last closing at US$56.61. The company focuses on immunology therapeutics for autoimmune and inflammatory diseases.
See our latest analysis for AnaptysBio.
Recent trading has been choppy. The stock has a 1-day share price return of 3.36% and 7-day share price return of 5.50%. However, it is down 14.73% over 30 days, while the year-to-date share price return is 25.94% and the 1-year total shareholder...